Table 1.
Cytokine | Diagnosis | CSF | Serum | ||||
---|---|---|---|---|---|---|---|
Valid | Not valid | % Valid | Valid | Not vallid | % Valid | ||
IFN-α2 | Cont | 0 | 21 | 0 | 20 | 1 | 95.2 |
IFN-α2 | FES | 0 | 20 | 0 | 20 | 0 | 100 |
IFN-γ | Cont | 0 | 21 | 0 | 13 | 8 | 61.9 |
IFN-γ | FES | 0 | 20 | 0 | 14 | 6 | 70 |
IL-10 | Cont | 0 | 21 | 0 | 20 | 1 | 95.2 |
IL-10 | FES | 2 | 18 | 10 | 20 | 0 | 100 |
IL-12p70 | Cont | 0 | 21 | 0 | 17 | 4 | 81 |
IL-12p70 | FES | 0 | 20 | 0 | 17 | 3 | 85 |
IL-17A | Cont | 0 | 21 | 0 | 19 | 2 | 90 |
IL-17A | FES | 1 | 19 | 5 | 19 | 1 | 95 |
IL-18 | Cont | 2 | 19 | 10 | 21 | 0 | 100 |
IL-18 | FES | 3 | 17 | 15 | 20 | 0 | 100 |
IL-1β | Cont | 0 | 21 | 0 | 6 | 15 | 29 |
IL-1β | FES | 0 | 20 | 0 | 2 | 18 | 10 |
IL-23 | Cont | 0 | 21 | 0 | 18 | 3 | 86 |
IL-23 | FES | 0 | 20 | 0 | 17 | 3 | 85 |
IL-33 | Cont | 0 | 21 | 0 | 19 | 2 | 90.5 |
IL-33 | FES | 0 | 20 | 0 | 20 | 0 | 100 |
IL-6 | Cont | 7 | 14 | 33.3 | 20 | 1 | 95.2 |
IL-6 | FES | 12 | 8 | 60 | 17 | 3 | 85 |
IL-8 | Cont | 20 | 1 | 95.2 | 19 | 2 | 90.48 |
IL-8 | FES | 20 | 0 | 100 | 20 | 0 | 100 |
MCP-1 | Cont | 21 | 0 | 100 | 20 | 1 | 95 |
MCP-1 | FES | 20 | 0 | 100 | 20 | 0 | 100 |
TNF-α | Cont | 0 | 21 | 0 | 16 | 5 | 76.2 |
TNF-α | FES | 0 | 20 | 0 | 15 | 5 | 75 |
Cytokine assays for which at least 2 out of the 3 replicates and > 50% of the samples gave readings above the LOD are indicated for CSF and serum control (CONT) and FES samples
The assays which passed these criteria are indicated in bold font